[The pharmacokinetics of long-circulating beta-elemene liposomes]
Bing-jiang Zhang1, Wei-chao Li, Xiao-ping Liu
1Hospital of Wuhan University of Technology, Wuhan 430070, China.
Summary
Long-circulating beta-elemene liposomes showed improved pharmacokinetic profiles compared to conventional liposomes. This suggests enhanced drug delivery and potentially better therapeutic efficacy for beta-elemene formulations.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Lipid Nanoparticle Technology
Background:
- Beta-elemene is a compound with therapeutic potential.
- Conventional liposomal formulations may have limitations in drug circulation time.
- Optimizing liposome design is crucial for enhancing drug pharmacokinetics.
Purpose of the Study:
- To evaluate the pharmacokinetic properties of long-circulating beta-elemene liposomes.
- To compare the performance of long-circulating liposomes against conventional liposomes.
- To assess the impact of liposome formulation on beta-elemene disposition in vivo.
Main Methods:
- Development and characterization of long-circulating beta-elemene liposomes.
- Establishment of a sensitive gas chromatography method for plasma beta-elemene quantification.
- Pharmacokinetic analysis in a rat model.
Main Results:
- Long-circulating beta-elemene liposomes exhibited significantly higher values for parameters such as alpha, T(1/2beta), K12, and AUC compared to conventional liposomes.
- Conventional liposomes showed lower values for T(1/2alpha), Vc, CL, and K10.
- These findings indicate a prolonged circulation time and altered distribution for the long-circulating formulation.
Conclusions:
- Long-circulating beta-elemene liposomes effectively prolong the in vivo residence time of beta-elemene.
- This enhanced pharmacokinetic profile suggests an improved potential for therapeutic efficacy.
- The study supports the use of long-circulating liposomes for optimizing beta-elemene drug delivery.
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...